CD44 and neoplasm: Multiple studies have demonstrated the involvement of tumor promoting ECM-integrin α5β1 interactions, tumor enhancing hyaluronan-CD44 interactions, and CAF-mediated TGFβ secretion in tumor progression [41–45].